Identification of Multiple Epstein-Barr Virus-induced Nuclear Antigens with Sera from Patients with Rheumatoid Arthritis

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1984 Oct 1

PMID 6090712

Citations 18

Authors

T B Sculley

P J Walker

D J Moss

J H Pope

Affiliations

Soon will be listed here.

Abstract

By means of the protein immunoblot technique, the Epstein-Barr virus (EBV) nuclear antigen (EBNA) could be identified in a variety of EBV-transformed cell lines with anti-EBNA-positive sera from normal donors. The molecular weight of EBNA expressed in each of the cell lines varied between 70,000 and 75,000 and was dependent upon the strain of infecting virus. In contrast, 15 of 21 sera from patients with rheumatoid arthritis identified antigens in addition to EBNA. The most prominent of these antigens had molecular weights of 110,000 to 115,000 and 92,000. All of the EBV genome-positive cell lines except for QIMR-GOR and cell lines containing the P3HR-1 virus expressed these antigens. The antigens were not present in the EBV genome-negative Ramos and BJAB cell lines, nor were they identified with EBV seronegative sera, indicating that they were EBV related. There was no direct correlation between the presence of antibodies in sera to EBNA, viral capsid antigen or early antigen, and reaction with the 92,000-molecular-weight antigen in immunoblots, indicating that this antigen was distinct from previously described EBV-related antigens.

Citing Articles

Detection of Epstein-Barr virus in synovial fluid of rheumatoid arthritis patients.

Mahabadi M, Faghihiloo E, Alishiri G, Ataee M, Ataee R Electron Physician. 2016; 8(3):2181-6.

PMID: 27123228 PMC: 4844486. DOI: 10.19082/2181.

Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary....

Yamazaki M, Kitamura R, Kusano S, Eda H, Sato S, Okawa-Takatsuji M Clin Exp Immunol. 2005; 139(3):558-68.

PMID: 15730403 PMC: 1809310. DOI: 10.1111/j.1365-2249.2004.02704.x.

Rheumatoid factors induce signaling from B cells, leading to Epstein-Barr virus and B-cell activation.

Yang L, Hakoda M, Iwabuchi K, Takeda T, Koike T, Kamatani N J Virol. 2004; 78(18):9918-23.

PMID: 15331725 PMC: 515018. DOI: 10.1128/JVI.78.18.9918-9923.2004.

Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses.

Leen A, Meij P, Redchenko I, Middeldorp J, Bloemena E, Rickinson A J Virol. 2001; 75(18):8649-59.

PMID: 11507210 PMC: 115110. DOI: 10.1128/jvi.75.18.8649-8659.2001.

Molecular virology of Epstein-Barr virus.

Bornkamm G, Hammerschmidt W Philos Trans R Soc Lond B Biol Sci. 2001; 356(1408):437-59.

PMID: 11313004 PMC: 1088437. DOI: 10.1098/rstb.2000.0781.

References

Henle G, Henle W . Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966; 91(3):1248-56. PMC: 316020. DOI: 10.1128/jb.91.3.1248-1256.1966. View

Epstein M, ACHONG B, BARR Y, Zajac B, Henle G, Henle W . Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst. 1966; 37(4):547-59. View

Pope J, ACHONG B, Epstein M, BIDDULPH J . Burkitt lymphoma in New Guinea: establishment of a line of lymphoblasts in vitro and description of their fine structure. J Natl Cancer Inst. 1967; 39(5):933-45. View

Pope J . Establishment of cell lines from Australian leukaemic patients: presence of a herpes-like virus. Aust J Exp Biol Med Sci. 1968; 46(5):643-5. DOI: 10.1038/icb.1968.171. View

Pope J, Horne M, Scott W . Identification of the filtrable leukocyte-transforming factor of QIMR-WIL cells as herpes-like virus. Int J Cancer. 1969; 4(3):255-60. DOI: 10.1002/ijc.2910040302. View

Hinuma Y, Konn M, Yamaguchi J, Wudarski D, Blakeslee Jr J, GRACE Jr J . Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J Virol. 1967; 1(5):1045-51. PMC: 375384. DOI: 10.1128/JVI.1.5.1045-1051.1967. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Miller G, Lipman M . Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus. J Exp Med. 1973; 138(6):1398-412. PMC: 2139465. DOI: 10.1084/jem.138.6.1398. View

Klein G, Dombos L . Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome. Int J Cancer. 1973; 11(2):327-37. DOI: 10.1002/ijc.2910110210. View

10.

Reedman B, Klein G . Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973; 11(3):499-520. DOI: 10.1002/ijc.2910110302. View

11.

Klein G, Lindahl T, Jondal M, Leibold W, Menezes J, Nilsson K . Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A. 1974; 71(8):3283-6. PMC: 388669. DOI: 10.1073/pnas.71.8.3283. View

12.

Fresen K, Hausen H . Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains. Int J Cancer. 1976; 17(2):161-6. DOI: 10.1002/ijc.2910170203. View

13.

Klein G, GIOVANELLA B, Westman A, STEHLIN J, Mumford D . An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology. 1975; 5(6):319-34. DOI: 10.1159/000149930. View

14.

Klein G, Zeuthen J, Terasaki P, Billing R, Honig R, Jondal M . Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines. Int J Cancer. 1976; 18(5):639-52. DOI: 10.1002/ijc.2910180513. View

15.

Powell A, King W, Kieff E . Epstein-Barr virus-specific RNA. III. Mapping of DNA encoding viral RNA in restringent infection. J Virol. 1979; 29(1):261-74. PMC: 353112. DOI: 10.1128/JVI.29.1.261-274.1979. View

16.

Hirsch I, Kuchlerova L, Brichacek B, SUCHANKOVA A, Vonka V . Blocking of acid-fixed nuclear binding of Epstein-Barr virus nuclear antigen (EBNA) by different DNA species. J Gen Virol. 1979; 44(3):849-52. DOI: 10.1099/0022-1317-44-3-849. View

17.

Aitcheson C, Peebles C, Joslin F, Tan E . Characteristics of antinuclear antibodies in rheumatoid arthritis. Reactivity of rheumatoid factor with a histone-dependent nuclear antigen. Arthritis Rheum. 1980; 23(5):528-38. DOI: 10.1002/art.1780230503. View

18.

Strnad B, Schuster T, Hopkins 3rd R, Neubauer R, Rabin H . Identification of an Epstein-Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis. J Virol. 1981; 38(3):996-1004. PMC: 171239. DOI: 10.1128/JVI.38.3.996-1004.1981. View

19.

Burnette W . "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981; 112(2):195-203. DOI: 10.1016/0003-2697(81)90281-5. View

20.

Spelsberg T, Sculley T, Pikler G, Gilbert J, Pearson G . Evidence for two classes of chromatin-associated Epstein-Barr virus-determined nuclear antigen. J Virol. 1982; 43(2):555-65. PMC: 256159. DOI: 10.1128/JVI.43.2.555-565.1982. View